That is very different than saying the extension study added nothing new.
It is big news considering it was increased dosage that provided NEW clinical data that was requested by potential partners. The only way you can take the position that the extension study was insignificant is if you believe Tim fabricated the whole story.
- Forums
- ASX - By Stock
- 1AD
- Ann: Corporate Presentation
1AD
adalta limited
Add to My Watchlist
0.00%
!
0.2¢

Ann: Corporate Presentation, page-100
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.225M |
Open | High | Low | Value | Volume |
0.2¢ | 0.3¢ | 0.2¢ | $11.25K | 5.461M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 12795213 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 16667741 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 12795213 | 0.002 |
18 | 54401501 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 16667741 | 19 |
0.004 | 10562189 | 12 |
0.005 | 800199 | 4 |
0.006 | 1963830 | 1 |
0.007 | 142999 | 2 |
Last trade - 15.59pm 25/07/2025 (20 minute delay) ? |
Featured News
1AD (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online